Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06165510 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation

Study acronym: CLIP-AF
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion pushed from Jun 1, 2026 to Nov 1, 2026
    • Study completion pushed from Oct 2026 to Nov 2026
    v5
  2. Primary completion date: Mar 1, 2026 to Jun 1, 2026v4
  3. Primary completion date: Mar 1, 2025 to Mar 1, 2026
    • Study completion date: Oct 2025 to Oct 2026
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2024 to Aug 2, 2024
    • Primary completion date: Aug 2025 to Mar 1, 2025
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A randomised controlled clinical trial to assess efficacy of convergent ablation with the LARIAT procedure, as compared to standard endocardial catheter ablation in patients with long-standing persistent atrial fibrillation (AF).
Trial Details
NCT Number NCT06165510
Lead Sponsor Barts & The London NHS Trust
Collaborators: AtriCure, Inc.
Conditions
(from sponsor)		 Persistent Atrial Fibrillation, Atrial Fibrillation, Persistent, Atrium; Fibrillation, Atrial Arrhythmia
Related terms Arrhythmias, Cardiac, Atrial Fibrillation
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov